About Us
NEUROSTECH is the only biotechnology company in the world that has designed, patented, manufactured, and preclinically tested human prototypes of pumpless devices and smart catheters for the intrathecal delivery of drugs or CSF clearance. Our proprietary technology enables the development of novel, medical devices to treat neurological diseases.
The company integrates innovation in neuroscience, biomedical engineering and precision dosing platforms at the time for implementing the most advanced manufacturing capabilities to deliver transformative therapies to patients.
Our technology takes advantage of the most advanced knowledge of CSF dynamics to develop medical devices for CSF clearance or drug delivery not possible by other strategies.
NEUROSTECH is a biotechnology company founded as a spin-off of the Fundación Neurociencias in Oviedo (Spain), and led by its co-founder Manuel Menéndez, MD, Ph.D., and supported by collaborations with leading neuroscientists in Europe and the USA, as well as by experienced managers, scientists and Business Development professionals.